YieldMax MSTR Option Income Strategy ETF vs Tilray Brands Inc — how do they compare? YieldMax MSTR Option Income Strategy ETF trades at $15.78 (market cap $1.11B), while Tilray Brands Inc trades at $3.64 (market cap $549.01M). The key difference: YieldMax MSTR Option Income Strategy ETF is far larger — about 2× Tilray Brands Inc's market cap, and YieldMax MSTR Option Income Strategy ETF is more actively traded (3,805,384 versus 3,292,073). Which is the better fit depends on your goals — on Pluang, investors hold YieldMax MSTR Option Income Strategy ETF for 30 Days and Tilray Brands Inc for 31 Days on average.
| MSTY | TLRY | |
|---|---|---|
Market Cap | $1.11B | $549.01M |
Volume | 3,805,384 | 3,292,073 |
Sector | Income / Options Overlay | Health |
52-Week High | $67.85 | $21.00 |
52-Week Low | $11.55 | $3.57 |
Typical Hold Time | 30 Days | 31 Days |
Enterprise Value | — | $716.15M |
Signals from Pluang's Aura AI — not financial advice
MSTY, the YieldMax MSTR Option Income Strategy ETF, trades at $15.83, down 5.61% with a bearish technical signal. The fund generates weekly distributions through options strategies on MicroStrategy stock, with recent payouts ranging from $0.16 to $0.34. Despite high distribution rates exceeding 100% annualized, the fund has experienced significant NAV erosion, declining approximately 34% over six months according to 24/7 Wall Street analysis from July 2026.
The outlook remains challenging as MSTY's strategy sacrifices capital appreciation for income generation. While the high distribution rate provides income, the structural erosion of NAV presents substantial risk. Investors face the dual challenge of receiving taxable distributions while experiencing principal decline, making this suitable only for those prioritizing current income over capital preservation.
Tilray Brands (TLRY) trades at $3.715, down 1.72% on the day, as the stock continues to face significant pressure with bearish technical signals and fundamental challenges. The company reported a substantial net loss of $2.19 billion in 2025 despite $821 million in revenue, with negative cash flow from operations of $94.6 million. Recent earnings have consistently missed expectations, and technical indicators show a bearish trend with the stock trading near key support levels.
While TLRY shows attractive valuation metrics with P/S of 0.45 and P/B of 0.34, the company faces substantial execution risks amid persistent losses and negative cash flow. Analyst sentiment remains cautious with only 25% buy ratings, though the consensus price target of $65.01 suggests significant upside potential if the company can achieve profitability and growth targets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →